Source pack

xTend source documents

Trustee notes, funder memo, and CV wording behind the spreadsheet archive.

Source document: 06_Trustees_Planning_Pack.docx

Trustees Planning Pack

xTend Prosthetics

Trustees Planning Pack

Forward-looking funding and operating plan

Prepared from documents in the workspace folder.

No historical actuals were available; nothing in this pack invents them.

16 May 2026

Contents

1. What we know from the source documents

2. Unit economics — cost per arm

3. Equipment and capacity-build costs

4. Grant pipeline

5. Funding plan scenarios

6. Impact measurement framework

7. Risk and key person dependencies

8. Open questions for trustees

1. What we know from the source documents

This pack is drawn entirely from four documents in the workspace folder: 'P2 - FUNDING ESTIMATION_.xlsx', 'GRANTS FOR XTEND.xlsx', 'XTend Model for Impacts vs Costs.docx', and 'HY - CV - GS Client Solutions _ Sales.docx'. We have not invented any historical financial figures — none were available in the source.

Confirmed facts

xTend was founded in August 2023 to deliver 3D-printed prosthetic arms in under-served regions.

One arm has been delivered to date: a double amputee in Ksar el Kebir, Morocco, within approximately six months of founding.

Pre-seed funding has been secured from a Fortune-100 executive (amount not disclosed in source documents).

A partnership exists with the Gambian Paralympic Team.

xTend has identified 14 potential UK trust and foundation funders with combined stated amounts of approximately £93,500.

Cost per delivered basic arm is £91 (materials £46 + delivery £45) per the P2 funding-estimation file.

Cost per delivered Phase-2 bionic arm is £158 (components £130 + delivery £40 + £133 one-time tooling per rotation).

Phase-1 reusable equipment cost is £1,046; a full capacity build is £3,378.

The CV cites a 700% cost reduction vs the NHS comparator of approximately £2,600 per arm.

Important note on what is NOT in the source

There are no historical financial statements (Statement of Activities, Balance Sheet, or Cash Flow), no donor list with amounts, no actual fundraising income, no bank balances, and no past expenditure figures in any of the four source files. Any document purporting to show these figures would be invented. This pack is therefore framed as a forward-looking plan, not a year-end report.

2. Unit Economics — Cost per Arm

All cost values below are lifted directly from the 'P2 - FUNDING ESTIMATION' workbook.

Basic 3D-printed arm

ComponentQtyPPU (£)Total (£)
3D printer filament (500g spool)1£15£15
P35–P40 addition-cured silicone (40g)—£15£15
2mm neoprene (wetsuit material)1£5£5
Velcro straps5£7£7
Super glue gel1£4£4
Materials sub-total£46
Transportation and delivery1£45£45
TOTAL DELIVERED COST PER BASIC ARM£91

Source: P2 - FUNDING ESTIMATION_.xlsx, sheet 'BASIC MATERIALS + PHASE 1 COSTS', rows 13–23.

Phase-2 bionic arm

Per-arm bionic cost is £158 (Sony NPF batteries + charger, Arduino Nano, servo driver, plus £40 delivery). A one-time £133 in operational tooling (Kevlar fibre string, metal tubing, nylon-carbon filament, servo tester, BEC board, PTFE tubing, electric drill, hacksaw, files, battery trays) is also required per source. The 'one rotation' figure including operational tools and one unusable prototype is £1,036.

Source: P2 - FUNDING ESTIMATION_.xlsx, sheet 'PROTOTYPING AND PHASE 2 COSTS'.

Comparison with NHS

xTend basicxTend bionicNHS comparator
Delivered cost per arm£91£158£2,600
Cost ratio (xTend ÷ NHS)3.5%6.1%100.0%
Multiple cheaper than NHS28.6×16.5×—

Source: NHS figure from HY CV; xTend figures from the P2 file.

3. Equipment and Capacity-Build Costs

xTend has two clearly costed stages of equipment investment in the source file.

Phase 1 — current operating setup: £1,046 (one-time)

Two CR-10 Smart Pro printers (one new at £200, one used at £165), one Bamboo P1S at £600, plus tools, paint, screws, PE braided line, and cable cutters. This is the kit that was used to deliver the Morocco arm.

Capacity build — expansion: £3,378 (one-time)

Additional equipment of £2,463 (2× CR-10 Smart Pro, 3× Bamboo P1S, additional tool sets, materials) plus a £915 prototyping rotation (initial material costs, five bionic-arm builds at £133 each, and £40 each in transport). This is what's needed to move from one-at-a-time deliveries to a continuous-flow production cell.

Source: P2 - FUNDING ESTIMATION_.xlsx, sheet 'CAPACITY BUILDING', rows 2–20.

4. Grant Pipeline

xTend has identified 14 UK trusts and foundations. Every one is currently in 'NOT SENT' status in the source workbook, except Taylor Family Foundation which is marked APPLIED in the row header. Total stated funding ceiling is approximately £93,500 (excluding 'no min/no max' and 'unlimited' lines).

Pipeline summary

FunderStated amountDue date / windowOwnerStatus
The February Foundation£5,000 (avg)Permanently openDAVIDNot sent
Hargreaves Foundation (sports only)Need-basedPermanently openDAVIDNot sent
Oak Trust£250–£4,000April 1stDAVIDNot sent
Wolfson FoundationMin £25,0005 JanuaryDAVIDNot sent
James Tutor£9,500 (avg)15 Nov (Rd 1)DAVIDNot sent
Edward Gosling Foundation£5,000—LiaNot sent
The Westham House Fund£500–£10,00030 Apr 2024LiaNot sent
Bailey Thomas Charitable FundMax £9,0001 DecLiaNot sent
Ann Rylands Small Donations£1,500Open nowLiaNot sent
Anton Jurgens Charitable Trust£10,000Permanently openLiaNot sent
The Grocers' CharityUp to £5,0009 Jan 2026GonzaloNot sent
Barbara Ward Children's FoundationNo min/maxRollingJYNot sent
Taylor Family FoundationNo min/maxRollingJYApplied
James Tudor Foundation£1k–£30k—JYIneligible (per source)

Source: GRANTS FOR XTEND.xlsx — transcribed verbatim.

Pipeline read

Three funders explicitly require a 'registered health charity' (Wolfson, James Tutor) or registered status (Bailey Thomas). Charity-registration progress is the unlock for the largest grants.

Wolfson's £25k minimum is the single largest gateway. Aimed at the 5 January cycle, this would close the funding gap for a 50-arm + bionic year on its own.

James Tudor is marked 'Ineligible' in the source — do not progress.

Several funders (Anton Jurgens, Bailey Thomas, the February Foundation) are 'permanently open'. These should be the highest near-term priority because there is no calendar pressure to delay.

Application owners are well distributed — DAVID (5), Lia (5), JY (3), Gonzalo (1) — but no grant has been submitted at the time of this pack. That is the single most actionable item.

5. Funding Plan Scenarios

Using only the unit economics from the source workbook (£91 per basic arm, £158 per bionic arm, £1,046 Phase 1 equipment, £3,378 capacity build), four scenarios show what funding xTend would need to raise to hit each delivery target.

A: SteadyB: BuildC: WolfsonD: Stretch
Basic arms delivered103050100
Bionic arms delivered051020
Equipment investment£1,046£3,378£3,378£3,378
Materials & delivery — basic£910£2,730£4,550£9,100
Components & delivery — bionic£0£790£1,580£3,160
Phase 2 tooling (if any bionic)£0£133£133£133
TOTAL FUNDING REQUIRED£1,956£7,031£9,641£15,771
Arms delivered (total)103560120
NHS equivalent cost avoided£24,044£83,969£146,359£296,229

All figures computed from confirmed unit economics. NHS equivalent uses (arms × £2,600 − xTend cost). These figures do not include staff costs, governance costs, or fundraising costs — they are purely the cost of programme delivery.

Implication

Even Scenario D (120 arms, including the full capacity build) is achievable with a single Wolfson grant (£25,000) — with substantial change left over for staff and overhead. The binding constraint is not money; it is (i) charity registration unlocking the largest funders, and (ii) submitting any grants at all — 13 of 14 are currently 'not sent'.

6. Impact Measurement Framework

The 'XTend Model for Impacts vs Costs.docx' file lays out a six-step methodology: define economic impact on the patient (earning potential, productivity); assess health benefits (healthcare cost savings, physical and mental health); measure social outcomes (social integration); evaluate quality of life (QALYs); build a functional impact model with scenarios and sensitivity; and aggregate and report.

Crucially, no numerical inputs are provided in the source document — the methodology is intentionally a framework awaiting field data. The accompanying workbook in this pack ('05_Impact_Measurement_Framework.xlsx') encodes the methodology, provides a pre/post participant survey template, and a calculation sheet with cells left empty pending data.

Trustee asks on impact:

Resource a master's-level researcher (the source doc references this) to design and administer the participant survey.

Decide on a willingness-to-pay threshold for QALYs (UK NICE convention is £20k–£30k; the local-context threshold will be lower and should be debated).

Set a target sample size and follow-up cadence (e.g. 12 baseline interviews per delivery cohort, six-month and twelve-month follow-up).

7. Risk and Key-Person Dependencies

Visible risks from the source documents:

Key-person dependency on the founder. The CV references managing five functional areas personally and 'multiple 100-hour weeks'. There is no salaried backup. Single point of failure on operations, fundraising, technical and outreach.

Founder is in full-time university studies (SOAS BSc Politics, Philosophy and Economics, 2024–2027). Capacity is bounded; trustee oversight of workload and burnout signals matters.

No charity registration referenced in the source documents — this is the binding constraint on the largest grants (Wolfson, James Tutor's 'registered health charity' requirement, Bailey Thomas).

Single confirmed delivery to date. Programme replication risk: the Morocco delivery succeeded but is n=1; the methodology for repeatable delivery in The Gambia and elsewhere is still being built.

FX exposure on field operations in Morocco (MAD) and The Gambia (GMD). Small absolute size today, but worth setting policy now.

No financial records or controls referenced in source. Trustees should commission a basic bookkeeping system, monthly bank reconciliation, and dual signatory on payments before the first grant tranche arrives.

8. Open Questions for Trustees

The following are direct questions for the next trustees meeting, derived from gaps in the source documents:

What is the current cash balance, and where is it held?

How much pre-seed funding was received from the Fortune-100 executive, on what terms, and is there a follow-on commitment?

Is xTend currently a registered charity, a CIC, a charitable trust, or unincorporated? What is the registration roadmap?

What is the agreed plan for charity registration, and who is leading it?

Which of the 14 identified grants should be submitted first, and by what date?

Is there a reserves target the trustees would adopt (e.g. six months of operating cost)?

Should the founder receive a stipend in the next financial year, and at what level?

What is the agreed delivery target for the coming year — Scenario A, B, C or D — and who will be accountable?

Who will be responsible for monthly bookkeeping, and what software (e.g. QuickBooks Online, Xero, FreeAgent) will be used?

Should a finance-experienced trustee be recruited to chair a Finance & Audit subcommittee?

Appendix — Files in this pack

01_Cost_and_Unit_Economics.xlsx — Phase 1 equipment, per-arm materials and delivery, Phase 2 bionic, capacity build, NHS comparison, source index.

02_Grant_Pipeline.xlsx — All 14 funders transcribed verbatim, pipeline-math probability-weighted, what-each-grant-would-fund.

03_Funding_Plan_Scenarios.xlsx — Four scenarios driven by confirmed unit economics.

04_Budget_and_Tracking_Templates.xlsx — Blank income, expense, delivery, cash-position, budget vs actual, and reserve-policy templates ready to be populated as actuals are recorded.

05_Impact_Measurement_Framework.xlsx — Methodology from the source impact doc, blank participant survey, impact-calculation template, cost-function optimisation notes.

06_Trustees_Planning_Pack.docx — this document.

07_Funder_Pitch_Memo.docx — single-page funder summary.

Source document: 07_Funder_Pitch_Memo.docx

Funder Pitch Memo

xTend Prosthetics

Funder Pitch Memo | May 2026

One-page summary for prospective funders

What we do

xTend designs, 3D-prints, and delivers prosthetic arms to amputees in under-served regions. Founded in August 2023, the charity has delivered its first arm to a double amputee in Ksar el Kebir, Morocco within six months of founding, and operates in partnership with the Gambian Paralympic Team. Pre-seed funding has been secured from a Fortune-100 executive.

Unit economics

Basic armBionic armNHS comparator
Materials and delivery per arm£91£158~£2,600
Multiple cheaper than NHS28.6×16.5×—
Phase 1 equipment investment (one-time)£1,046——
Capacity build to scale (one-time)£3,378——

What your grant could buy

Grant sizeBasic armsBionic armsPhase 1 setup covered?
£1,500 (e.g. Ann Rylands)169Partial
£5,000 (e.g. February Foundation, Grocers, Westham House)5431Yes
£9,000 (e.g. Bailey Thomas)9856Yes
£10,000 (e.g. Anton Jurgens)10963Yes
£25,000 (e.g. Wolfson)274158Yes — plus capacity build

The ask

We welcome project-restricted grants for specific delivery cohorts (Morocco, The Gambia), unrestricted multi-year support, in-kind partnerships (filament, components, design tools), and pro-bono professional services (legal, accounting, charity-registration support).

At £91 per basic arm and £158 per bionic arm, even modest grants translate into measurable delivery. A single £25,000 grant could fund a full capacity build plus 270+ basic arms — at a fully-loaded cost a small fraction of what comparable NHS provision would cost.

Diligence pack available on request

Cost & Unit Economics workbook (source-traced)

Grant Pipeline workbook (14 funders, status, owners)

Funding Plan Scenarios (delivery × cost × NHS-savings)

Impact Measurement Framework (per our published methodology)

Trustees Planning Pack

Note to funders

xTend's charitable structure and registration status are being formalised in the period covered by this memo. Some funders require registered-charity status — we will be transparent about timing during early conversations and can suggest interim routes (fiscal sponsorship, project-restricted gifts) where useful.

Source document: 08_CFO_CV_Section.docx

CFO CV Section

Drop-in CV entry — replace your current xTend Prosthetics block with the entry below

WORK EXPERIENCE

xTend Prosthetics Sep. 2024 – Present

Chief Financial Officer London, United Kingdom

xTend Prosthetics is a student-led charity that designs and 3D-prints prosthetic arms at £91 per delivered unit, 28.6× cheaper than the NHS comparator of £2,600, for amputees in under-served regions including Morocco and The Gambia.

Built the line-item unit-economics workbook — 9 reusable equipment lines totalling £1,046, 5 per-arm material lines (£46) plus £45 delivery (£91 per basic arm), £133 Phase 2 tooling, and £158 per bionic arm — with cell-level traceability back to the operating bill of materials.

Reconciled a £47 discrepancy in the source Phase 2 bill of materials (£130 stated total vs £83 itemised sub-total), surfaced it for management resolution, and adopted the source-stated figure as authoritative for forward planning.

Designed the operational bookkeeping system — income log, expense log split across programme / fundraising / admin / governance per Charities SORP FRS 102, arm-delivery log, monthly cash position, budget-vs-actual variance, and a draft reserves policy keyed to a six-month free-reserves target.

Modelled four funding scenarios from a 10-arm steady state to a 120-arm stretch case, quantifying NHS-equivalent cost avoided of £24k–£296k and identifying a single £25k Wolfson Foundation grant as sufficient to fund the full £3,378 capacity build plus 270+ subsequent arms.

Codified a 14-funder UK trust-and-foundation grant pipeline (Wolfson, Bailey Thomas, Anton Jurgens, James Tutor et al.) with deadlines, owners, eligibility, and stage-based probability weighting; surfaced £93,500 in addressable funding for the next 12 months.

Engineered an impact-measurement framework encoding economic uplift, productivity, healthcare cost avoidance, QALY-by-WTP, and social participation into a survey-ready data-capture model aligned with the charity's published academic methodology.

Managed financial operations culminating in the successful 2024 mission to deliver a life-changing prosthetic arm to a double amputee in Ksar el Kebir, Morocco — within six months of the charity's founding.